ABSTRACT
Background Record numbers of new cases and deaths registered in Japan and European countries in early 2022 once again proved that existing vaccines cannot stop the new infections and deaths caused by SARS-CoV-2 and aroused new questions about methods of overcoming the pandemic.
Aim of the study to compare the pandemic waves in Japan, Ukraine, USA, Hong Kong, mainland China, European and African countries in 2020, 2021, 2022 and to investigate the influence of testing and vaccination levels.
Methods The smoothed daily numbers of new cases and deaths per capita, the ratio of these characteristics and the non-linear correlation with the tests per case ratio were used.
Results As in other countries, the deaths per case ratio in Japan decreases with the increase of the vaccination level. Non-linear correlation revealed, that the daily number of new cases drastically decreases with the increase of the tests per case ratio.
Conclusions Increasing the level of testing (especially for people who may have contact with infected persons) and adhering to quarantine restrictions for the entire population, including vaccinated people, may be recommended to end the pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
inesteruk{at}yahoo.com
Data Availability
All data produced in the present work are contained in the manuscript